Heparin Sodium Injectable

본문 바로가기


Home > Product > Heparin Sodium Injectable
Product
Heparin Sodium Injectable
Posting date : Jan 18, 2016
Membership
Free Member Scince Dec 26, 2015
FOB Price
usd17
Min. Order Quantity
1000mega
Supply Abillity
10ton/year
Port
Beijing
Payment Terms
TT
Package
Aluminum
Keyword :
Category
Contact
Vicky Liu
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
sheelian
HS-CODE
3001-90
Package & Delivery Lead Time
Package
Aluminum
Delivery Lead Time
14DAYS
Detailed Description
English name: Heparin sodiumEnglish synonyms: SODIUM HEPARIN;SODIUM HEPARINATE;REVIPARIN SODIUM;PORCINE HEPARIN SODIUM.BOVINEHEPARIN SODIUM.ENOXAPARIN SODIUM;HEP, NA, BOVINE;HEP, NA, PORCINECAS no. : 9041 - 08-1Formula: (C12H16NS2Na3) 20Molecular weight: ca. 12000EINECS no. : 232-681-7Solubility: H2O: 50 mg/ml clear, faintly yellowForm: crystalline (fine)Color: white,Merck: 14465 3Stability: Stable. Incompatible with strong oxidizing agents, strong outside.Than the curl: not less than 50 ° +Ph: 5-8 -Protein: 0.5% or lessDry weight loss: 5.0% or lessOn ignition residue: 28.0 to 41.1%Avoiding titer: 202.3 IU/mgWet product potency: 204.3 IU/mgPacking: packed in aluminum drumThe physical and chemical properties: heparin sodium is white or kind of white powder, odorless, has led to wet, soluble in water, insoluble in ethanol, acetone and other organic solvents.inIn aqueous solution, have a strong negative charge, can combine with some cation into molecular complex.A stable aqueous solution at pH 7.
 Function:A- Used to prevent thrombosis and embolism, such as deep vein thrombosis, myocardial infarction, pulmonary embolism, thrombotic phlebitis and postoperative thrombosis, etc.
B- Treatment of diffuse intravascular coagulation (DIC)  caused by various reasons, such as bacterial sepsis, placental abruption, and for the DIC caused by malignant tumor lysis.
 
C- Can prevent the consumption of fibrinogen and other blood coagulation factor .D- For other anticoagulant in vivo and in vitro, such as cardiac catheterization , cardiac surgery extracorporeal circulation, hemodialysis, and so on.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top